PATENT CLAIM ANALYSIS

Application Number: 15945073
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "110000"]

Abstract:
The present invention provides novel methods of treating triple-negative breast cancer (TNBC). In certain embodiments, the methods of the invention do not require the use of ionizing radiation therapies. In other embodiments, the methods of the invention do not harm non-cancerous cells.

Claim (Index 3):
The method of  claim 2 , wherein the administration of the compound does not cause any, or causes insignificant, apoptosis in non-cancerous cells.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 91.0
- Lexical Diversity: 1.58065
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15486183', '14798208', '14760711', '15127973', '15371104']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7420994289835687
- 35 USC 102 Novelty (BERT): 0.4969839581620066
- Combined Prediction Score: 0.7175878819014125
- Mean Citation Score: 215.029126
- Max Citation Score: 224.25081
- Similarity Product: 158.96957573401448

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test